1. Linear Accelerator (LINAC) Radiosurgical Management of Brain Arteriovenous Malformations: An Experience From a Tertiary Care Center.
- Author
-
Mohan A, Tiwari S, Pareek P, Fernandes A, Santhyavu S, Kombathula SH, Choubisa M, Gayen S, Irfad M, and Solanki A
- Abstract
Introduction: Brain arteriovenous malformations (AVM) are complex vascular pathologies with a significant risk of hemorrhage. Stereotactic radiosurgery (SRS) is an effective treatment modality for AVM, initially popularized on the Gamma Knife (Elekta AB, Stockholm, Sweden) platform, and now benefits from the modern advances in linear accelerator (LINAC)-based platforms. This study evaluates the outcomes of LINAC-based SRS/hypofractionated stereotactic radiotherapy (hFSRT) for cerebral AVMs., Materials and Methods: Between December 2018 and April 2024, 15 patients with cerebral AVMs underwent SRS/hFSRT at a tertiary government hospital. Patient selection was based on AVM size, location, surgical unsuitability, and patient preference. All patients underwent MRI and cerebral angiography for nidus delineation. SRS was planned using Monaco TPS (treatment planning system) (Elekta AB, Stockholm, Sweden) with VMAT (volumetric modulated arc therapy) technique, delivering a median dose of 20 Gy in single fractions for small AVMs and 28 Gy in four fractions for large AVMs. Patients were followed up with annual MRI and angiography to assess obliteration., Results: The cohort had a median age of 22 years, with a median nidus volume of 3.76 cc. The crude obliteration rate was 60%, confirmed by MRI/angiography. Actuarial obliteration rates at two, three, and five years were 65.71%, 73.57%, and 77.14%, respectively. Smaller AVMs (<3 cc) and those with a modified AVM radiosurgery score <1.5 had nearly 100% obliteration rates. Large AVMs (>10 cc) treated with hypofractionated SRT showed partial responses only. Significant predictors of obliteration included prescription dose, AVM volume, and modified AVM radiosurgery score., Conclusion: LINAC-based SRS demonstrates comparable efficacy to other modalities for treating cerebral AVMs, with obliteration rates influenced by dose, AVM volume, and pre-treatment radiosurgery score. Larger AVMs pose a greater challenge, suggesting a need for adjunctive treatments or higher fractionated doses to improve outcomes., Competing Interests: Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. Institutional Ethics Committee, All India Institute of Medical Sciences, Jodhpur issued approval AIIMS/IEC/2018/782; dated December 22, 2018. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work., (Copyright © 2024, Mohan et al.)
- Published
- 2024
- Full Text
- View/download PDF